rs144564120

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS3PM1PP3_ModeratePP5_Very_Strong

The NM_000400.4(ERCC2):​c.2150C>G​(p.Ala717Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000446 in 1,613,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000322086: RNA studies suggest that the c.2150C>G variant creates a cryptic splice donor site upstream of the natural splice site, leading to an in-frame deletion of 15 amino acids (PMID:7585650)" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. A717A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00046 ( 0 hom. )

Consequence

ERCC2
NM_000400.4 missense

Scores

15
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:13U:1O:1

Conservation

PhyloP100: 9.00

Publications

20 publications found
Variant links:
Genes affected
ERCC2 (HGNC:3434): (ERCC excision repair 2, TFIIH core complex helicase subunit) The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
ERCC2 Gene-Disease associations (from GenCC):
  • cerebrooculofacioskeletal syndrome 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • trichothiodystrophy 1, photosensitive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • xeroderma pigmentosum group D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
  • sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichothiodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum-Cockayne syndrome complex
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000322086: RNA studies suggest that the c.2150C>G variant creates a cryptic splice donor site upstream of the natural splice site, leading to an in-frame deletion of 15 amino acids (PMID: 7585650); Published functional studies also suggest that A717G was similar to wildtype in UV survival assays and TFIIH binding, but when expressed in cis with L461V, cells were more sensitive at high doses of UV; however, the significance of this result is unclear due to a lack known controls (PMID: 25716912);; SCV002228642: Experimental studies have shown that this missense change affects ERCC2 function (PMID: 7585650, 15982307, 25716912).; SCV000914845: Horibata et al. (2015) performed functional studies demonstrating that the (p.Leu461Val; p.Val716_Arg730del) allele was functionally null in nucleotide excision repair and not able to form the TFIIH complex. Zhou et al. (2013) also showed that the (p.Leu461Val; p.Val716_Arg730del) allele exhibited decreased DNA repair.; SCV004812413: "In vitro nucleotide excision repair (NER) and transcription assays in NER-deficient cell lines showed p.Val716_Arg730del exhibited defective repair and transcriptional activity, while p.Ala717Gly exhibited efficient repair and transcriptional activity. The combined p.[Leu461Val;Ala717Gly] exhibited intermediate activity." PMID: 25716912; SCV003654229: Additional functional assays showed that XPD protein with the V716_R730 deletion is defective in nucleotide excision repair activity and could not form the TFIIH complex (Horibata, 2015).; SCV003800757: "At least one publication reports experimental evidence evaluating an impact of the complex allele on protein function (example, Horibata_2015). The most pronounced variant effect abolishes the helicase, Nucleotide Excision Repair (NER) activity and the transcriptional activity of TFIIH. However, although individually, p.Leu461Val and p.Ala717Gly possessed full NER activity (comparable to p.WT), the combined mutant p.[Leu461Val; Ala717Gly] possessed only partial NER activity. Due to the data presented as immunoprecipitation data on blots, an exact residual activity for the combined mutant cannot be ascertained from this report. Horibata_2015"; SCV003800758: At least one publication reports experimental evidence evaluating an impact of the complex allele on protein function (example, Horibata_2015). The most pronounced variant effect abolishes the helicase, Nucleotide Excision Repair (NER) activity and the transcriptional activity of TFIIH. However, although individually, p.Leu461Val and p.Ala717Gly possessed full NER activity (comparable to p.WT), the combined mutant p.[Leu461Val; Ala717Gly] possessed only partial NER activity.
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 21 uncertain in NM_000400.4
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 19-45352249-G-C is Pathogenic according to our data. Variant chr19-45352249-G-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 134102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000400.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERCC2
NM_000400.4
MANE Select
c.2150C>Gp.Ala717Gly
missense
Exon 22 of 23NP_000391.1P18074-1
ERCC2
NM_001440355.1
c.2078C>Gp.Ala693Gly
missense
Exon 22 of 23NP_001427284.1
ERCC2
NM_001440356.1
c.2072C>Gp.Ala691Gly
missense
Exon 21 of 22NP_001427285.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERCC2
ENST00000391945.10
TSL:1 MANE Select
c.2150C>Gp.Ala717Gly
missense
Exon 22 of 23ENSP00000375809.4P18074-1
ERCC2
ENST00000391944.8
TSL:1
c.2150C>Gp.Ala717Gly
missense
Exon 22 of 22ENSP00000375808.4E7EVE9
ERCC2
ENST00000391941.6
TSL:1
c.2078C>Gp.Ala693Gly
missense
Exon 21 of 21ENSP00000375805.2A8MX75

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
41
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000314
AC:
79
AN:
251244
AF XY:
0.000331
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00228
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000361
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000465
AC:
679
AN:
1461776
Hom.:
0
Cov.:
33
AF XY:
0.000451
AC XY:
328
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33478
American (AMR)
AF:
0.000224
AC:
10
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00214
AC:
56
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86256
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53368
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5746
European-Non Finnish (NFE)
AF:
0.000506
AC:
563
AN:
1111982
Other (OTH)
AF:
0.000530
AC:
32
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000269
AC:
41
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.000145
AC:
6
AN:
41442
American (AMR)
AF:
0.0000655
AC:
1
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000424
Hom.:
0
Bravo
AF:
0.000272
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000346
AC:
42
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
1
-
Xeroderma pigmentosum, group D (4)
3
-
-
not provided (3)
2
-
-
Xeroderma pigmentosum, group D;C1853102:Cerebrooculofacioskeletal syndrome 2;C1866504:Trichothiodystrophy 1, photosensitive (2)
1
-
-
ERCC2-related disorder (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified (1)
1
-
-
Trichothiodystrophy 1, photosensitive (1)
1
-
-
Xeroderma pigmentosum (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.084
T
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
35
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.17
T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
9.0
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-2.5
N
REVEL
Uncertain
0.58
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.038
D
Polyphen
0.015
B
Vest4
0.62
MVP
0.89
MPC
0.30
ClinPred
0.64
D
GERP RS
5.3
Varity_R
0.42
gMVP
0.43
Mutation Taster
=6/94
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.87
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.87
Position offset: 5

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144564120; hg19: chr19-45855507; COSMIC: COSV109439200; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.